Oncotype DX score # those with Recurrence or Metastasis

Options
I just wonder if the Oncotype DX score number of those with recurrence or matasisis follows the clinical trial studies of the low/mid/high range..Since this is a newer test that if in the mid range you really need to base a low % of benefit of chemo vs the se's of chemo.....I don't believe any test/preceedure/meds will give us a guarantee but thought it might be interesting for those of us on this site trying to learn and understand all we can....Thank you for any input....

Categories